ReviewExpert review of vaccines2020
Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections.
James Logue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it